T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Automatic Data Processing
ADP
$107B
| $265M | 0.05% |
3,094,622
-158,384
| -5% | -$13.6M |
|
|
XLNX
377
DELISTED
Xilinx Inc
XLNX
| $263M | 0.05% |
6,225,555
+92,867
| +2% | +$3.81M |
|
|
CMCSK
378
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $263M | 0.05% |
4,690,798
-209,042
| -4% | -$11.7M |
|
379
Lazard
LAZ
$4.24B
| $262M | 0.05% |
4,981,010
-47,220
| -0.9% | -$2.33M |
|
|
YHOO
380
DELISTED
Yahoo Inc
YHOO
| $261M | 0.05% |
5,866,450
+3,616,001
| +161% | +$164M |
|
381
Regency Centers
REG
$13.9B
| $258M | 0.05% |
3,797,055
+243,430
| +7% | +$16.4M |
|
382
CNA Financial
CNA
$13.7B
| $257M | 0.05% |
6,201,266
+748,128
| +14% | +$30.1M |
|
383
Monro
MNRO
$359M
| $257M | 0.05% |
3,946,880
-107,250
| -3% | -$6.57M |
|
384
Iron Mountain
IRM
$37B
| $256M | 0.05% |
7,008,079
-137,115
| -2% | -$5.29M |
|
|
CYT
385
DELISTED
CYTEC INDS INC
CYT
| $256M | 0.05% |
4,729,509
+10,900
| +0.2% | +$544K |
|
386
Graco
GGG
$13.4B
| $255M | 0.05% |
10,591,041
+191,535
| +2% | +$4.77M |
|
387
Barclays
BCS
$94.4B
| $255M | 0.05% |
18,799,723
+361,999
| +2% | +$5.07M |
|
388
Coca-Cola Europacific Partners
CCEP
$47.3B
| $254M | 0.05% |
5,751,283
+3,360,566
| +141% | +$147M |
|
389
Acadia Realty Trust
AKR
$2.84B
| $253M | 0.05% |
7,245,449
+307,379
| +4% | +$10.7M |
|
390
Ally Financial
ALLY
$13.5B
| $252M | 0.05% |
12,017,393
+4,283,213
| +55% | +$90.2M |
|
|
WUBA
391
DELISTED
58.com Inc
WUBA
| $252M | 0.05% |
4,766,935
+730,175
| +18% | +$30.9M |
|
392
Aramark
ARMK
$15.9B
| $251M | 0.05% |
10,992,330
+3,863,458
| +54% | +$88.5M |
|
393
Halliburton
HAL
$27.7B
| $246M | 0.05% |
5,608,873
+2,332,937
| +71% | +$97.3M |
|
394
Campbell Soup
CPB
$6.74B
| $245M | 0.05% |
5,254,418
-20,520
| -0.4% | -$947K |
|
395
Landstar System
LSTR
$6.31B
| $244M | 0.05% |
3,673,509
-601,910
| -14% | -$40.8M |
|
396
Centene
CNC
$33.1B
| $243M | 0.05% |
6,867,090
+308,366
| +5% | +$9.27M |
|
|
SE
397
DELISTED
Spectra Energy Corp Wi
SE
| $242M | 0.05% |
6,690,204
-376,821
| -5% | -$13.2M |
|
|
P
398
DELISTED
Pandora Media Inc
P
| $242M | 0.05% |
14,898,385
+177,376
| +1% | +$2.84M |
|
399
CoStar Group
CSGP
$12.4B
| $241M | 0.05% |
12,183,510
-27,450
| -0.2% | -$518K |
|
|
ATHN
400
DELISTED
Athenahealth, Inc.
ATHN
| $237M | 0.05% |
1,982,572
+4,724
| +0.2% | +$630K |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.